All Treatments
Strong EvidencePeptide

Semaglutide

The Ozempic molecule

GLP-1 Receptor Agonist

Last updated: November 2024

Evidence Level: Strong Evidence

Multiple large human trials, FDA approval, established safety profile

Regulatory Status: FDA-approved for diabetes (Ozempic) and weight loss (Wegovy)

Semaglutide is a synthetic version of GLP-1, a hormone your body naturally makes after eating. It tells your brain you're full and slows digestion. Originally developed for type 2 diabetes, it turned out to be remarkably effective for weight loss—so effective that it launched the current GLP-1 revolution.

How It Works

Semaglutide mimics the GLP-1 hormone that your gut releases when you eat. But while natural GLP-1 lasts only minutes, semaglutide stays active for about a week (that's why it's a weekly injection).

It works through several mechanisms:
Brain: Reduces appetite and food cravings at the source
Stomach: Slows emptying so you feel full longer
Pancreas: Improves insulin release and blood sugar control
Liver: Reduces glucose production

The net effect: you naturally eat less without the constant battle against hunger that sabotages traditional diets.

Potential Benefits

  • 15-17% average weight loss in clinical trials (vs 2-3% for placebo)
  • Significantly reduced appetite and food cravings
  • Improved blood sugar control and insulin sensitivity
  • Cardiovascular benefits (reduced heart attack and stroke risk in some populations)
  • Weekly injection (convenient, not daily)
  • Well-established safety profile from years of use

Risks & Considerations

  • GI side effects are common (nausea, vomiting, diarrhea, constipation)—usually improve over time
  • Muscle loss can occur if protein intake is inadequate
  • Rare risk of pancreatitis (severe abdominal pain = call doctor immediately)
  • Contraindicated with personal/family history of medullary thyroid cancer
  • May cause gallbladder problems in some users
  • Expensive without insurance ($1,000+/month retail)
  • Shortage issues can make it hard to find

Dosing Information

Semaglutide is titrated slowly to minimize side effects. Most protocols start at 0.25mg weekly for 4 weeks, then increase gradually.

  • Starting dose: 0.25mg/week (this is sub-therapeutic—for adjustment only)
  • Typical escalation: 0.25 → 0.5 → 1.0 → 1.7 → 2.4mg
  • Each dose increase = 4 weeks minimum
  • Maximum approved dose for weight loss: 2.4mg/week
  • Never start at a high dose—GI side effects will be severe

Practical Tips

  • 1Inject on the same day each week (pick a day and stick to it)
  • 2Rotate injection sites: stomach, thigh, or upper arm
  • 3Store in refrigerator before first use; can keep at room temp for up to 28 days after
  • 4Eat protein first at every meal to protect muscle mass
  • 5Stay ahead of constipation with fiber and water
  • 6If you miss a dose: take it within 5 days, then resume schedule

Key Research

STEP 1 Trial

New England Journal of Medicine, 2021

Participants lost an average of 14.9% body weight vs 2.4% with placebo over 68 weeks.

SELECT Trial

New England Journal of Medicine, 2023

Reduced cardiovascular events (heart attack, stroke) by 20% in people with obesity and heart disease.

Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any treatment. Evidence levels and regulatory status can change—this content was last updated November 2024.